ZURICH, June 29 (Reuters) - A patient with H1N1 influenza in Denmark showed resistance to Roche Holding AG's antiviral Tamiflu, a company executive said on Monday.
"This is the first case we have of it in H1N1," David Reddy, Roche's pandemic taskforce leader, told reporters on a conference call. (Reporting by Sam Cage)